Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016.
Accord Healthcare, a generic pharmaceutical company, has opened a new facility in Fawdon, Newcastle, expanding its portfolio to four sites situated within the UK.
Global innovator and provider of cold chain packaging systems for the pharma industry, Softbox, has acquired TP3 Global, which manufactures the ‘SilverSkin’ brand.
The collaboration between AstraZeneca and TissUse is progressing with the establishment of relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology, the companies announced.
Micro filtration and single-use system specialist, Meissner Filtration Products, has acquired a supplier of advanced aseptic filling systems and sealers to the pharmaceutical industry, PDC Aseptic Filling Systems.
Health systems are facing the biggest challenge in their existence: financial sustainability fuelled by the costs of prescription drugs. Here, Marisa Miraldo, associate professor at Imperial College Business School, goes into more detail…
The Association of the British Pharmaceutical Industry (ABPI) has released research showing that the amount of capital invested alongside corporate venture capital (CVC) in UK biotech increased six-fold between 2010 and 2015.
The RSA Group, has published a new study analysing the performance of biotechnology boards, CEOs and chairs from both Europe and the US, from an investor viewpoint, demonstrating that European companies are outperforming US ones
In this latest instalment of our ‘Meet the maker’ series, we talk with John Fowler who was recently appointed as chief operating officer at Piramal Pharma Solutions — a contract development and manufacturing organisation (CDMO)
Here, Giovanni Rizzo, PhD, MBA, chief of Innovation Division, Z-Cube, reveals what life science start-ups should bear in mind when looking for funding.
Global health science marketing and communications firm, SCORR Marketing, has released a new study, in partnership with Applied Clinical Trials, evaluating the extent to which collaborations occur in the life sciences what influences them
